By FMTeam Though Ranbaxy Laboratories is an old company, but it was recently acquired by Sun Pharma back in 2014, and that was a big point in the history of this company itself. And it could very well be the case that this company wasn’t that well-known before Sun Pharma took over, but let’s just get to know a little more about it by talking about things like Ranbaxy Laboratories Net Worth, Owner, CEO, Head Office, etc.
| Company Name | Ranbaxy Laboratories Limited (Now merged) |
| Establishment Year | 1961 |
| Head Office | Gurgaon, Haryana, India |
| Owner/Founder | Ranbir Singh and Gurbax Singh (Original Founders); Sun Pharma (Current Owner) |
| CEO Name | Arun Sawhney was the last CEO before the merger |
| Industry | Pharmaceuticals |
| Number of Employees | Approximately 15,300 |
| Net Worth / Market Cap | Not applicable today |
| Total Revenue in 2026 | Not applicable for 2026 |
Company Overview
Initially, Ranbaxy Laboratories was started up by two cousins in 1937, Ranbir Singh and Gurbax Singh. The word “Ranbaxy” was formed by joining parts of the two cousins’ names. In 1952, the firm was bought by businessman Bhai Mohan Singh, who ultimately decided the destiny of the business. With his guidance, Ranbaxy was formally registered in 1961 and later became a very large pharmaceutical manufacturer with its headquarters, aka main head office, still there in Gurgaon, Haryana. Talking about some recent stuff, well, in 2015, the merger was done successfully, which means that Ranbaxy has ended its path as a standalone pharmaceutical company.
Ranbaxy Laboratories Net Worth
We can’t tell you much about Ranbaxy Laboratories’ net worth or even market cap because there aren’t good estimates available out there.
Current Status And Future Stuff
Currently, the Ranbaxy brand and its business dealings have been fully merged with Sun Pharmaceutical Industries. Sun Pharma is currently ranked among the largest specialty generic pharmaceutical manufacturers globally. Hence, all decisions concerning the erstwhile Ranbaxy operations are made by Sun Pharma. In addition, Sun Pharma had to resolve a number of legal and regulatory issues that were inherited from Ranbaxy, amongst which were settlements of the cases in the US. Moving ahead, the manufacturing facilities and the product range that were previously owned by Ranbaxy have been supporting the global pharmaceutical business of Sun Pharma.